
AI Selloff Deepens, Oil Jumps and Crypto Falls
Reporting on market developments concerning AI Selloff Deepens, Oil Jumps and Crypto Falls. Industry analysts and investors are monitoring the operational, strategic, and financial...
Query our full-text historical index across market dispatches, earnings reports, central bank policies, and financial analyses.

Reporting on market developments concerning AI Selloff Deepens, Oil Jumps and Crypto Falls. Industry analysts and investors are monitoring the operational, strategic, and financial...

Digital assets dropped across the board as reports of a major protocol breach sparked cascading liquidations and reignited systemic security concerns.

Alphabet has lost approximately $500 billion in market value as Wall Street scrutinizes mounting artificial intelligence expenditures and escalating antitrust headwinds.

U.S. equities pulled back as a sharp drop in Alphabet shares sparked broader concerns over the timeline and payoff of massive artificial intelligence spending.

Campari shares dropped sharply after the Italian spirits maker warned that intensifying competition and logistics bottlenecks in the crucial U.S. market are dampening growth.

Alphabet shares tumbled following quarterly results as investors weighed surging artificial intelligence infrastructure spending against advertising revenue trends.

A selloff swept across major artificial intelligence and semiconductor equities following Alphabet's latest quarterly results, raising investor scrutiny over rising infrastructure expenditures.

Global crude benchmarks retreated as energy traders recalibrated risk premiums following diplomatic overtures between Washington and Tehran.

Moderna Chief Executive Stéphane Bancel remains steadfast on the company's individualized cancer vaccine program despite recent equity selloffs and shifting market expectations.

Alphabet shares tumbled sharply, threatening to erase over $300 billion in shareholder value as investors reassess tech capital expenditures and competitive AI threats.

Boston Scientific shares slid as softer-than-expected sales momentum raised questions about hospital procedural volumes and medtech demand.

Adyen shares tumbled after the Dutch payments giant walked back its midterm profitability guidance, signaling persistent margin pressures across global fintech.